Merck & Co Inc. Blog | Talkmarkets

Latest Posts

Merck Rises, Bristol-Myers Slides Following Cancer Meeting

Article By: The Fly

Monday, April 16, 2018 11:09 AM EDT

Shares of Merck are rising this morning, while peer Bristol-Myers is sliding, after both companies presented new data on their respective cancer immunotherapy treatments at the American Association for Cancer Research annual meeting.

In this article: BMY, MRK

Read

The 8 'Dogs Of The Dow' Hit Hard In First Quarter, Here's How To Trade Them Now

Article By: Richard Suttmeier

Sunday, April 8, 2018 8:00 AM EDT

The eight "Dogs of the Dow" for 2018 ended March with an aggregate loss of 7.5% year-to-date.

In this article: CVX, IBM, KO, MRK, PFE, PG, VZ, XOM

Read

NewLink Genetics Plunges After Competitor IDO Drug Fails In Trial

Article By: The Fly

Friday, April 6, 2018 1:08 PM EDT

Shares of NewLink Genetics (NLNK), a clinical-stage company focused on cancer, plunged in pre-market trading after a competitor exploring the same areas of cancer treatment reported a clinical trial that did not succeed in achieving its goal.

In this article: MRK, NLNK, NKTR

Read

2018 Dogs Of The Dow

Article By: Gavin McMaster

Wednesday, March 21, 2018 4:15 AM EDT

The Dogs of the Dow theory was created in 1972 and has proven to be successful more often than not over the years. Sometimes the simple things work the best and this strategy is simplicity to the core.

In this article: GE, IBM, MRK, VZ, XOM

Read

Merck (MRK) Beats On Q4 Earnings, Lags Sales, Guides For '18

Article By: Zacks Investment Research

Friday, February 2, 2018 11:45 AM EDT

Merck & Co., Inc. reported fourth-quarter 2017 adjusted earnings of 98 cents per share, which beat the Zacks Consensus Estimate of 94 cents by 4.3%. Earnings rose 10.1% year over year.

In this article: MRK Also: GSK, JNJ, SNY

Read

All Posts